While CCR2+ myeloid cells contribute to tumor cell metastasis, CCR2+ endothelium is activated by CRC-derived CCL2, which increases vascular permeability and cancer cell extravasation through the JAK2-Stat5 and p38MAPK pathways [36]. Here, CCL2 is linked to neoplasm.